Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, September 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 160 articles:
HTML format


 

Single Articles

  1. GUSTIN E, Jarc E, Kump A, Petan T, et al
    Lipid Droplet Formation in HeLa Cervical Cancer Cells Depends on Cell Density and the Concentration of Exogenous Unsaturated Fatty Acids.
    Acta Chim Slov. 2017;64:549-554.
    Abstract    

    Abstract available

  2. LAGANA AS, Rosa VL, Fanale D, Vitale SG, et al
    Comment on: Survey of cervical cancer survivors regarding quality of life and sexual function.
    J Cancer Res Ther. 2017;13:598-599.
    Abstract    



  3. SINGH S, Hussain S, Badaya S
    Prospects of cytological cervical cancer screening in India: Exploring adjuvant approaches.
    J Cancer Res Ther. 2017;13:389-391.
    Abstract    



  4. WANG JM, Ju BH, Pan CJ, Gu Y, et al
    MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
    Am J Transl Res. 2017;9:3541-3557.
    Abstract    

    Abstract available

  5. CHEN YF, Tang WB, Pan XX, Wu CR, et al
    Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer.
    Onco Targets Ther. 2017;10:4113-4119.
    Abstract    

    Abstract available

  6. CUI Y, Zhang X, You K, Guo Y, et al
    Nanomechanical Characteristics of Cervical Cancer and Cervical Intraepithelial Neoplasia Revealed by Atomic Force Microscopy.
    Med Sci Monit. 2017;23:4205-4213.
    Abstract    

    Abstract available

  7. ZHOU L, Qin J, Ma L, Li H, et al
    Rosoloactone: A natural diterpenoid inducing apoptosis in human cervical cancer cells through endoplasmic reticulum stress and mitochondrial damage.
    Biomed Pharmacother. 2017;95:355-362.
    Abstract    

    Abstract available

  8. BAHLS L, Yamakawa R, Zanao K, Alfieri D, et al
    Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  9. CHAN DNS, So WKW
    Translation and validation of translation in cross-cultural research: Strategies used in a study of cervical cancer screening among ethnic minorities.
    Int J Nurs Pract. 2017 Aug 31. doi: 10.1111/ijn.12581.
    Abstract    

    Abstract available

  10. WEI L, Qin XP, Zhao XX, Wang W, et al
    [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:551-557.
    Abstract    

    Abstract available

  11. LINDEGAARD JC, Assenholt M, Ramlov A, Fokdal LU, et al
    Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Acta Oncol. 2017 Aug 29:1-8. doi: 10.1080/0284186X.2017.1349335.
    Abstract    

    Abstract available

  12. JIA L, Zhang Y, Tian F, Chu Z, et al
    Long noncoding RNA colon cancer associated transcript1 promotes the proliferation, migration and invasion of cervical cancer.
    Mol Med Rep. 2017 Aug 21. doi: 10.3892/mmr.2017.7302.
    Abstract    

    Abstract available

  13. CHENG Y, Geng L, Zhao L, Zuo P, et al
    Human papillomavirus E6-regulated microRNA-20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.
    Mol Med Rep. 2017 Aug 11. doi: 10.3892/mmr.2017.7231.
    Abstract    

    Abstract available

  14. YUCE SARI S, Guler OC, Gultekin M, Onal HC, et al
    Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient.
    Oncol Res Treat. 2017;40:523-527.
    Abstract    



  15. FANG SQ, Feng YM, Li M
    Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study.
    Oncol Res Treat. 2017;40:533-539.
    Abstract    



  16. LIU T, Li S, Ratcliffe J, Chen G, et al
    Assessing Knowledge and Attitudes towards Cervical Cancer Screening among Rural Women in Eastern China.
    Int J Environ Res Public Health. 2017;14.
    Abstract    

    Abstract available

  17. QUERCIA K, Tran PL, Jinoro J, Herniainasolo JL, et al
    A Mobile Health Data Collection System for Remote Areas to Monitor Women Participating in a Cervical Cancer Screening Campaign.
    Telemed J E Health. 2017 Aug 28. doi: 10.1089/tmj.2017.0146.
    Abstract    

    Abstract available

  18. MATSUO K, Purushotham S, Moeini A, Li G, et al
    A pilot study in using deep-learning to predict limited life-expectancy in women with recurrent cervical cancer.
    Am J Obstet Gynecol. 2017 Aug 23. pii: S0002-9378(17)30947.
    Abstract    



  19. GALLO F, Caprioglio A, Castagno R, Ronco G, et al
    Inequalities in cervical cancer screening utilisation and results: A comparison between Italian natives and immigrants from disadvantaged countries.
    Health Policy. 2017 Aug 10. pii: S0168-8510(17)30205.
    Abstract    

    Abstract available

  20. OBA S, Toyoshima M, Ogata H
    Association of Cervical Cancer Screening with Knowledge of Risk Factors, Access to Health Related Information, Health Profiles, and Health Competence Beliefs among Community-Dwelling Women in Japan
    Asian Pac J Cancer Prev. 2017;18:2115-2121.
    Abstract    

    Abstract available

  21. ZHU H, Chen A, Li S, Tao X, et al
    Predictive Role of Galectin-1 and Integrin alpha5beta1 in Cisplatin-based Neoadjuvant Chemotherapy of Bulky Squamous Cervical Cancer.
    Biosci Rep. 2017 Aug 25. pii: BSR20170958. doi: 10.1042/BSR20170958.
    Abstract    

    Abstract available

  22. TERRACCIANO E, D'Alo GL, Aquilani S, Aversa AM, et al
    [HPV vaccination: active offer in an Italian region].
    Ig Sanita Pubbl. 2017;73:77-94.
    Abstract    

    Abstract available

  23. BERT F, Gualano MR, Clemente S, Villa G, et al
    [Technology and prevention in the era of mobile health: applications for cancer screening programs].
    Ig Sanita Pubbl. 2017;73:13-27.
    Abstract    

    Abstract available

  24. SUH DH, Kim M, Kim K, Kim HJ, et al
    Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.
    J Gynecol Oncol. 2017;28:e45.
    Abstract    

    Abstract available

  25. SMITH JS, Sanusi B, Swarts A, Faesen M, et al
    A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
    Am J Obstet Gynecol. 2017;217:183.
    Abstract    

    Abstract available

  26. MARKOVIC-DENIC L, Popovac S, Djuric O, Perisic Z, et al
    Psychological effects of concurrent cytology and colposcopy testing in women referred to cancer counseling outpatient clinic in Belgrade.
    J BUON. 2017;22:214-223.
    Abstract    

    Abstract available

  27. PODOLAK I, Kisia C, Omosa-Manyonyi G, Cosby J, et al
    Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya.
    BMC Health Serv Res. 2017;17:222.
    Abstract    

    Abstract available

  28. CIAVATTINI A, Clemente N, Tsiroglou D, Sopracordevole F, et al
    Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?
    Arch Gynecol Obstet. 2017;295:997-1003.
    Abstract    

    Abstract available

  29. PAPOUTSIS D, Underwood M, Parry-Smith W, Panikkar J, et al
    Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study.
    Arch Gynecol Obstet. 2017;295:979-986.
    Abstract    

    Abstract available

  30. PANDA PK, Behera B, Meher BR, Das DN, et al
    Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.
    Mol Carcinog. 2017;56:389-401.
    Abstract    

    Abstract available

  31. ZHANG S, Ma L, Meng QW, Zhou D, et al
    Comparison of laparoscopic-assisted radical vaginal hysterectomy and abdominal radical hysterectomy in patients with early stage cervical cancer: A retrospective study.
    Medicine (Baltimore). 2017;96:e8005.
    Abstract    

    Abstract available

  32. AMIR-KHALILI A, Hamarneh G, Zakariaee R, Spadinger I, et al
    Propagation of registration uncertainty during multi-fraction cervical cancer brachytherapy.
    Phys Med Biol. 2017 Sep 8. doi: 10.1088/1361-6560.
    Abstract    

    Abstract available

  33. KOZAKI M, Sakuma S, Kudaka W, Kinjyo Y, et al
    Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy.
    Arch Gynecol Obstet. 2017 Sep 7. doi: 10.1007/s00404-017-4520.
    Abstract    

    Abstract available

  34. MARTH C, Landoni F, Mahner S, McCormack M, et al
    Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2017;28.
    Abstract    



  35. HAN X, Wen H, Ju X, Chen X, et al
    Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases.
    Oncotarget. 2017;8:51840-51847.
    Abstract    

    Abstract available

  36. LI B, Li X, Xiong H, Zhou P, et al
    Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells.
    Oncotarget. 2017;8:51748-51757.
    Abstract    

    Abstract available

  37. CAO HZ, Liu XF, Yang WT, Chen Q, et al
    LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cell Death Dis. 2017;8:e3039.
    Abstract    

    Abstract available

  38. RWAMUGIRA J, Maree JE, Mafutha N
    The Knowledge of South African Men Relating to Cervical Cancer and Cervical Cancer Screening.
    J Cancer Educ. 2017 Sep 6. doi: 10.1007/s13187-017-1278.
    Abstract    

    Abstract available

  39. VARADARAJAN I, Basu A, Besmer S, Poli J, et al
    Solitary Skeletal Muscle Metastasis as First Site of Recurrence of Cervical Cancer: A Case Report.
    Case Rep Oncol. 2017;10:694-698.
    Abstract    

    Abstract available

  40. TSUJIMOTO N, Miyoshi A, Mimura M, Naka T, et al
    Case Report: Pulmonary Tumor Thrombotic Microangiopathy in a Cervical Cancer Patient.
    Gynecol Obstet Invest. 2017 Sep 7. doi: 10.1159/000480400.
    Abstract    

    Abstract available

  41. ZEITOUN O, Shemesh N
    THE LEVEL OF BREAST AND CERVICAL CANCER AWARENESS AMONG WOMEN IN A RURAL AREA OF SOUTH AFRICA.
    S Afr J Surg. 2017;55:47.
    Abstract    

    Abstract available

  42. MCGINNIS E, Meyerson BE, Meites E, Saraiya M, et al
    Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.
    Sex Transm Dis. 2017 Jun 19. doi: 10.1097/OLQ.0000000000000659.
    Abstract    

    Abstract available

  43. NIU AQ, Cao YH, Wang H, Zhang X, et al
    Role of IL17A rs2275913 and rs3748067 polymorphisms in the risk cervical cancer.
    Genet Mol Res. 2017;16.
    Abstract    

    Abstract available

  44. PERKINS RB, Cain JM, Feldman S
    Using Risk Stratification to Reduce Medical Errors in Cervical Cancer Prevention.
    JAMA Intern Med. 2017 Sep 5. doi: 10.1001/jamainternmed.2017.3999.
    Abstract    



  45. KIM M, Kim H, Suh DH, Kim K, et al
    Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer.
    Anticancer Res. 2017;37:5087-5094.
    Abstract    

    Abstract available

  46. THEODORE C, Levaillant JM, Capmas P, Chabi N, et al
    MRI and Ultrasound Fusion Imaging for Cervical Cancer.
    Anticancer Res. 2017;37:5079-5085.
    Abstract    

    Abstract available

  47. KIM BW, Cho H, Ylaya K, Kitano H, et al
    Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.
    Anticancer Res. 2017;37:4873-4879.
    Abstract    

    Abstract available

  48. LI YP, Zhang L, Zou YL, Yu Y, et al
    Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer.
    Asian Pac J Trop Med. 2017;10:680-684.
    Abstract    

    Abstract available

  49. LAMPE R, Poka R
    [Comparison of laparoscopic and open radical hysterectomies in the surgical treatment of cervical cancer].
    Orv Hetil. 2017;158:1403-1409.
    Abstract    

    Abstract available

  50. FETCKO K, Gondim DD, Bonnin JM, Dey M, et al
    Cervical cancer metastasis to the brain: A case report and review of literature.
    Surg Neurol Int. 2017;8:181.
    Abstract    

    Abstract available

  51. BALOCH Z, Yasmeen N, Li Y, Zhang W, et al
    Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women.
    Med Sci Monit. 2017;23:4269-4277.
    Abstract    

    Abstract available

  52. LIU W, Zhang X, Zhao J, Li J, et al
    Inhibition of cervical cancer cell metastasis by benzothiazole through up-regulation of E-cadherin expression.
    Microb Pathog. 2017 Aug 31. pii: S0882-4010(17)30967.
    Abstract    

    Abstract available

  53. MEDINA-ALARCON KP, Voltan AR, Fonseca-Santos B, Moro IJ, et al
    Highlights in nanocarriers for the treatment against cervical cancer.
    Mater Sci Eng C Mater Biol Appl. 2017;80:748-759.
    Abstract    

    Abstract available

  54. YAN K, Ramirez E, Xie XJ, Gu X, et al
    Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer.
    Pract Radiat Oncol. 2017 Jul 8. pii: S1879-8500(17)30195.
    Abstract    

    Abstract available

  55. ZEHBE I, Wakewich P, King AD, Morrisseau K, et al
    Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women.
    BMJ Open. 2017;7:e017384.
    Abstract    

    Abstract available

  56. BAUSSANO I, Lazzarato F, Ronco G, Lehtinen M, et al
    Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.
    J Infect Dis. 2017;216:336-344.
    Abstract    

    Abstract available

  57. MOCKLER D, Escobar-Hoyos LF, Akalin A, Romeiser J, et al
    Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
    Am J Clin Pathol. 2017;148:264-273.
    Abstract    

    Abstract available

  58. BAGGAR S, Ouahbi H, Azegrar M, El M'rabet FZ, et al
    [Neuroendocrine carcinoma of the cervix: a case report and review of the literature].
    Pan Afr Med J. 2017;27:82.
    Abstract    

    Abstract available

  59. SUN L, Zhang J, Yang Q, Si Y, et al
    Synergistic Effects of SAM and Selenium Compounds on Proliferation, Migration and Adhesion of HeLa Cells.
    Anticancer Res. 2017;37:4433-4441.
    Abstract    

    Abstract available

  60. WANG L, Qi Y, Xiong Y, Peng Z, et al
    Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Anticancer Res. 2017;37:4353-4360.
    Abstract    

    Abstract available

  61. HUANG RF, He C, Zhu WF, Li Y, et al
    [Application of immunohistochemistry for p16 and GATA3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma].
    Zhonghua Bing Li Xue Za Zhi. 2017;46:388-392.
    Abstract    

    Abstract available

  62. WU X, Zhao J, Cui XL, Li Q, et al
    [Prevalence of type-specific human papillomavirus infection among 18-45 year-old women from the general population in Liuzhou, Guangxi Zhuang Autonomous Region: a cross-sectional study].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:467-471.
    Abstract    

    Abstract available

  63. KIM MK, Jung YS, Chon SJ, Yun BH, et al
    Common Causes of Postmenopausal Bleeding in Korean Women: 10-Year Outcomes from a Single Medical Center.
    J Korean Med Sci. 2017;32:830-834.
    Abstract    

    Abstract available

  64. ZHANG X, Smits AH, van Tilburg GB, Jansen PW, et al
    An Interaction Landscape of Ubiquitin Signaling.
    Mol Cell. 2017;65:941-955.
    Abstract    

    Abstract available

  65. DITTMANN J, Ziegfeld A, Jansen L, Gajda M, et al
    Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
    Mol Carcinog. 2017;56:1578-1589.
    Abstract    

    Abstract available

  66. SENAPATI R, Nayak B, Kar SK, Dwibedi B, et al
    HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
    BMC Infect Dis. 2017;17:30.
    Abstract    

    Abstract available

  67. XIE G, Wang Z, Chen Y, Zhang S, et al
    Dual blocking of PI3K and mTOR signaling by NVP-BEZ235 inhibits proliferation in cervical carcinoma cells and enhances therapeutic response.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30712.
    Abstract    

    Abstract available

  68. WU Z, Qin Y, Yu L, Lin C, et al
    Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study.
    J Med Virol. 2017;89:535-541.
    Abstract    

    Abstract available

  69. FU HC, Yang YC, Chen YJ, Lin H, et al
    Correction: Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation.
    Oncotarget. 2017;8:55767.
    Abstract    

    Abstract available

  70. KOZASA K, Mabuchi S, Komura N, Yokoi E, et al
    Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review.
    Oncotarget. 2017;8:55394-55404.
    Abstract    

    Abstract available

  71. LI S, Yang F, Wang M, Cao W, et al
    miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/beta-catenin pathway in cervical cancer.
    Int J Mol Med. 2017;40:1047-1056.
    Abstract    

    Abstract available

  72. LAI Y, Fan L, Zhao Y, Ge H, et al
    Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NFkappaB signalling pathway.
    Int J Oncol. 2017;51:1159-1168.
    Abstract    

    Abstract available

  73. GUO S, Yang B, Liu H, Li Y, et al
    Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
    J Cancer Res Ther. 2017;13:689-692.
    Abstract    

    Abstract available

  74. VORNO T, Lutsar K, Uuskula A, Padrik L, et al
    Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31183.
    Abstract    

    Abstract available

  75. LAVELLE AE, Su D, Kahesa C, Soliman AS, et al
    Needs for Professional Education to Optimize Cervical Cancer Screenings in Low-Income Countries: a Case Study from Tanzania.
    J Cancer Educ. 2017 Sep 11. doi: 10.1007/s13187-017-1276.
    Abstract    

    Abstract available

  76. CAO S, Sun J, Lin S, Zhao L, et al
    HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer.
    Onco Targets Ther. 2017;10:4205-4211.
    Abstract    

    Abstract available

  77. WU X, Cao X, Chen F
    LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer.
    Oncol Res. 2017 Aug 31. doi: 10.3727/096504017X15037515496840.
    Abstract    

    Abstract available

  78. WANG X, Xie Y, Wang J
    Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2.
    Oncol Res. 2017 Aug 30. doi: 10.3727/096504017X15037506066252.
    Abstract    

    Abstract available

  79. NGUYEN-TRUONG CK, Tang J, Hsiao CY
    Community Interactive Research Workshop Series: Community Members Engaged as Team Teachers to Conduct Research.
    Prog Community Health Partnersh. 2017;11:215-221.
    Abstract    

    Abstract available

  80. CHEN YJ, Chang CL, Lee WR, Liou J, et al
    RASSF4 controls SOCE and ER-PM junctions through regulation of PI(4,5)P2.
    J Cell Biol. 2017;216:2011-2025.
    Abstract    

    Abstract available

  81. GRANADILLO M, Batte A, Blanco A, Alfonso AB, et al
    LALF32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.
    Clin Exp Metastasis. 2017;34.
    Abstract    

    Abstract available

  82. LAN K, Chen X, Liu Q, Fan Y, et al
    [Highly expressed sulfiredoxin and beta-catenin are associated with malignancy of cervical squamous cell carcinoma].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:376-379.
    Abstract    

    Abstract available

  83. LIU HL, Chen CM, Pai LW, Hwu YJ, et al
    Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database.
    Arch Gynecol Obstet. 2017;295:935-941.
    Abstract    

    Abstract available

  84. BARDACH AE, Garay OU, Calderon M, Pichon-Riviere A, et al
    Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.
    BMC Public Health. 2017;17:152.
    Abstract    

    Abstract available

  85. TING YH, Tse HY, Lam WC, Chan KS, et al
    The pattern of cervical smear abnormalities in marginalised women in Hong Kong.
    Hong Kong Med J. 2017;23:28-34.
    Abstract    

    Abstract available

  86. NERON M, Ferron G, Vieille P, Letouzey V, et al
    Treatment of neovaginal prolapse: case report and systematic review of the literature.
    Int Urogynecol J. 2017;28:41-47.
    Abstract    

    Abstract available

  87. FOWLER CI, Saraiya M, Moskosky SB, Miller JW, et al
    Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:981-985.
    Abstract    

    Abstract available

  88. FILADE TE, Dareng EO, Olawande T, Fagbohun TA, et al
    Attitude to Human Papillomavirus Deoxyribonucleic Acid-Based Cervical Cancer Screening in Antenatal Care in Nigeria: A Qualitative Study.
    Front Public Health. 2017;5:226.
    Abstract    

    Abstract available

  89. KOMDEUR FL, Prins TM, van de Wall S, Plat A, et al
    CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
    Oncoimmunology. 2017;6:e1338230.
    Abstract    

    Abstract available

  90. SHARKAS G, Arqoub K, Khader Y, Nimri O, et al
    Trends in the Incidence of Cervical Cancer in Jordan, 2000-2013.
    J Oncol. 2017;2017:6827384.
    Abstract    

    Abstract available

  91. BERGER T, Petersen JBB, Lindegaard JC, Fokdal LU, et al
    Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
    Acta Oncol. 2017 Sep 21:1-7. doi: 10.1080/0284186X.2017.1376753.
    Abstract    

    Abstract available

  92. LIU Y, Yang Y, Li L, Liu Y, et al
    LncRNA SNHG1 enhances cell proliferation, migration and invasion in cervical cancer.
    Biochem Cell Biol. 2017 Sep 20. doi: 10.1139/bcb-2017-0188.
    Abstract    

    Abstract available

  93. RODER D, Davy M, Selva-Nayagam S, Gowda R, et al
    The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia.
    Eur J Cancer Care (Engl). 2017 Sep 20. doi: 10.1111/ecc.12760.
    Abstract    

    Abstract available

  94. UYSAL TORAMAN A, Yildirim N
    Knowledge About Cervical Cancer Risk Factors and Practices of Pap Testing Among Turkish Immigrant Women in the United States.
    J Immigr Minor Health. 2017 Sep 19. doi: 10.1007/s10903-017-0653.
    Abstract    

    Abstract available

  95. MENG X, Zhao Y, Wang J, Gao Z, et al
    Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.
    Exp Ther Med. 2017;14:2789-2794.
    Abstract    

    Abstract available

  96. RASPAGLIESI F, Bogani G, Spinillo A, Ditto A, et al
    Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience.
    Eur J Surg Oncol. 2017 Sep 7. pii: S0748-7983(17)30654.
    Abstract    

    Abstract available

  97. CARDOSO MFS, Castelletti CHM, Lima-Filho JL, Martins DBG, et al
    Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Mutat Res. 2017;773:161-173.
    Abstract    

    Abstract available

  98. ACHARYA PANDEY R, Karmacharya E
    Cervical cancer screening behavior and associated factors among women of Ugrachandi Nala, Kavre, Nepal.
    Eur J Med Res. 2017;22:32.
    Abstract    

    Abstract available

  99. SHI C, Zhang Z
    MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.
    Oncol Lett. 2017;14:3809-3816.
    Abstract    

    Abstract available

  100. WEI ZT, Yu XW, He JX, Liu Y, et al
    Characteristics of primary side population cervical cancer cells.
    Oncol Lett. 2017;14:3536-3544.
    Abstract    

    Abstract available

  101. WANG X, Jiang Y, Yuan M, Chen C, et al
    Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.
    Oncol Lett. 2017;14:2813-2821.
    Abstract    

    Abstract available

  102. SUNDARAM MK, Ansari MZ, Mutery AA, Ashraf M, et al
    Genistein induces alterations of epigenetic modulatory signatures in human cervical cancer cells.
    Anticancer Agents Med Chem. 2017 Sep 18. doi: 10.2174/1871520617666170918142114.
    Abstract    

    Abstract available

  103. FRIESE K, Kost B, Vattai A, Marme F, et al
    The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2017 Sep 18. doi: 10.1007/s00432-017-2510.
    Abstract    

    Abstract available

  104. TANG J, Yang Z, Wang Z, Li Z, et al
    Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer.
    World J Surg Oncol. 2017;15:173.
    Abstract    

    Abstract available

  105. YUAN YG, Gurunathan S
    Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.
    Int J Nanomedicine. 2017;12:6537-6558.
    Abstract    

    Abstract available

  106. VALENTI G, Vitale SG, Tropea A, Biondi A, et al
    Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?
    Updates Surg. 2017 Sep 16. doi: 10.1007/s13304-017-0491.
    Abstract    

    Abstract available

  107. SCHERNBERG A, Reuze S, Orlhac F, Buvat I, et al
    A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.
    Eur J Nucl Med Mol Imaging. 2017 Sep 15. doi: 10.1007/s00259-017-3824.
    Abstract    

    Abstract available

  108. DONG L, Hu SY, Zhang Q, Feng R, et al
    Risk Prediction of Cervical Cancer and Precancers by Type-specific Human Papillomavirus: Evidence from a Population-based Cohort Study in China.
    Cancer Prev Res (Phila). 2017 Sep 15. pii: canprevres.0088.2017.
    Abstract    

    Abstract available

  109. ZHEN X, Chen J, Zhong Z, Hrycushko BA, et al
    Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study.
    Phys Med Biol. 2017 Sep 15. doi: 10.1088/1361-6560.
    Abstract    

    Abstract available

  110. LIN J, Lu J, Wang C, Xue X, et al
    The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer.
    Cancer Cell Int. 2017;17:80.
    Abstract    

    Abstract available

  111. SONG ZC, Ding L, Ren ZY, Sun XS, et al
    [Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:1246-1251.
    Abstract    

    Abstract available

  112. LLEWELYN M, Taylor A
    Re-irradiation of cervical and endometrial cancer.
    Curr Opin Oncol. 2017;29:343-350.
    Abstract    

    Abstract available

  113. KIM HS, Kim M, Luo Y, Lee M, et al
    Favorable factors for preserving bladder function after nerve-sparing radical hysterectomy: A protocol-based validation study.
    J Surg Oncol. 2017;116:492-499.
    Abstract    

    Abstract available

  114. BEAN LM, Ward KK, Plaxe SC, McHale MT, et al
    Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Am J Obstet Gynecol. 2017;217:332.
    Abstract    

    Abstract available

  115. KRANJEC C, Holleywood C, Libert D, Griffin H, et al
    Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch.
    J Pathol. 2017;242:448-462.
    Abstract    

    Abstract available

  116. YOSHIMATSU Y, Nakahara T, Tanaka K, Inagawa Y, et al
    Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
    Cancer Sci. 2017;108:1303-1309.
    Abstract    

    Abstract available

  117. MAERTENS JA, Jimenez-Zambrano AM, Albright K, Dempsey AF, et al
    Using Community Engagement to Develop a Web-Based Intervention for Latinos about the HPV Vaccine.
    J Health Commun. 2017;22:285-293.
    Abstract    

    Abstract available

  118. MORALES-CAMPOS DY, Parra-Medina D
    Predictors of Human Papillomavirus Vaccine Initiation and Completion Among Latino Mothers of 11- to 17-Year-Old Daughters Living Along the Texas-Mexico Border.
    Fam Community Health. 2017;40:139-149.
    Abstract    

    Abstract available

  119. NEVIS IF, Vali B, Higgins C, Dhalla I, et al
    Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review.
    J Robot Surg. 2017;11:1-16.
    Abstract    

    Abstract available

  120. TALIA KL, Stewart CJR, Howitt BE, Nucci MR, et al
    HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.
    Am J Surg Pathol. 2017;41:1023-1033.
    Abstract    

    Abstract available

  121. ROMA AA, Park KJ, Xie H, De Vivar AD, et al
    Role of Lymphovascular Invasion in Pattern C Invasive Endocervical Adenocarcinoma.
    Am J Surg Pathol. 2017;41:1205-1211.
    Abstract    

    Abstract available

  122. BURGER EA, Pedersen K, Sy S, Kristiansen IS, et al
    Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway.
    Br J Cancer. 2017 Aug 3. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  123. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    Abstract    

    Abstract available

  124. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    Abstract    

    Abstract available

  125. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    Abstract    

    Abstract available

  126. KANG Z, Stevanovic S, Hinrichs CS, Cao L, et al
    Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping and Monitoring.
    Clin Cancer Res. 2017 Sep 12. pii: clincanres.1553.2017.
    Abstract    

    Abstract available

  127. TSAI CY, Junod R, Jacot-Guillarmod M, Beniere C, et al
    Vaginal Enterobius vermicularis diagnosed on liquid-based cytology during papanicolaou test cervical cancer screening: A report of two cases and a review of the literature.
    Diagn Cytopathol. 2017 Sep 14. doi: 10.1002/dc.23812.
    Abstract    

    Abstract available

  128. RAUH LA, Pannone AF, Cantrell LA
    Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31333.
    Abstract    

    Abstract available

  129. AZAIS H, Ghesquiere L, Petitnicolas C, Borghesi Y, et al
    Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Gynecol Oncol. 2017 Sep 14. pii: S0090-8258(17)31334.
    Abstract    

    Abstract available

  130. CHAN JK, Deng W, Higgins RV, Tewari KS, et al
    A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jul 17. pii: S0090-8258(17)30889.
    Abstract    

    Abstract available

  131. HUO D, Anderson D, Palmer JR, Herbst AL, et al
    Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Gynecol Oncol. 2017;146:566-571.
    Abstract    

    Abstract available

  132. MOSS HA, Havrilesky LJ, Chino J
    Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
    Gynecol Oncol. 2017 Jun 19. pii: S0090-8258(17)30953.
    Abstract    

    Abstract available

  133. LOPEZ LABROUSSE MI, Frumovitz M, Guadalupe Patrono M, Ramirez PT, et al
    Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF).
    Gynecol Oncol. 2017;146:676-677.
    Abstract    

    Abstract available

  134. PETA E, Cappellesso R, Masi G, Sinigaglia A, et al
    Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
    Hum Pathol. 2017;61:33-40.
    Abstract    

    Abstract available

  135. VELEZ-PEREZ A, Wang XI, Li M, Zhang S, et al
    SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma.
    Hum Pathol. 2017;59:102-107.
    Abstract    

    Abstract available

  136. KOENEMAN MM, van Lint FH, van Kuijk SM, Smits LJ, et al
    A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters.
    Hum Pathol. 2017;59:62-69.
    Abstract    

    Abstract available

  137. KHAN S, Oosterhuis K, Wunderlich K, Bunnik EM, et al
    Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
    Int J Cancer. 2017;141:393-404.
    Abstract    

    Abstract available

  138. CLARKE MA, Luhn P, Gage JC, Bodelon C, et al
    Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Int J Cancer. 2017;141:701-710.
    Abstract    

    Abstract available

  139. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    Abstract    

    Abstract available

  140. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    Abstract    

    Abstract available

  141. ZHANG X, Ding J, Tao X, Qian H, et al
    Diagnosis and treatment of cervical papillary squamous cell carcinoma with unknown depth of stromal invasion.
    Int J Gynaecol Obstet. 2017;138:190-193.
    Abstract    

    Abstract available

  142. HAN Y, Li N, Zhang R, Li X, et al
    Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
    Int J Gynaecol Obstet. 2017;137:150-156.
    Abstract    

    Abstract available

  143. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    Abstract    

    Abstract available

  144. NIE JC, Yan AQ, Liu XS
    Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the Treatment of Cervical Cancer.
    Int J Gynecol Cancer. 2017 Aug 31. doi: 10.1097/IGC.0000000000001101.
    Abstract    

    Abstract available

  145. AL-HARBI NM, Bin Judia SS, Mishra KN, Shoukri MM, et al
    Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
    Int J Gynecol Cancer. 2017 Sep 13. doi: 10.1097/IGC.0000000000001103.
    Abstract    

    Abstract available

  146. DONG J, Su M, Chang W, Zhang K, et al
    Long non-coding RNAs on the stage of cervical cancer (Review).
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5905.
    Abstract    

    Abstract available

  147. LIANG H, Luo R, Chen X, Zhao Y, et al
    miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2017 Aug 23. doi: 10.3892/or.2017.5916.
    Abstract    

    Abstract available

  148. LEO PJ, Madeleine MM, Wang S, Schwartz SM, et al
    Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
    PLoS Genet. 2017;13:e1006866.
    Abstract    

    Abstract available

  149. PALATNIK A, Ye S, Kendziorski C, Iden M, et al
    Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
    PLoS One. 2017;12:e0181242.
    Abstract    

    Abstract available

  150. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    Abstract    

    Abstract available

  151. AZZOLLINI J, Pesenti C, Ferrari L, Fontana L, et al
    Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.
    PLoS One. 2017;12:e0171663.
    Abstract    

    Abstract available

  152. RHODES CM, Chang Y, Regan S, Triant VA, et al
    Non-Communicable Disease Preventive Screening by HIV Care Model.
    PLoS One. 2017;12:e0169246.
    Abstract    

    Abstract available

  153. MOLBAK K, Hansen ND, Valentiner-Branth P
    Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    PLoS One. 2016;11:e0162520.
    Abstract    

    Abstract available

  154. LU Y, Wei JY, Yao DS, Pan ZM, et al
    Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer.
    PLoS One. 2017;12:e0183834.
    Abstract    

    Abstract available

  155. MUSA J, Achenbach CJ, O'Dwyer LC, Evans CT, et al
    Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0183924.
    Abstract    

    Abstract available

  156. GININDZA TG, Sartorius B, Dlamini X, Ostensson E, et al
    Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.
    PLoS One. 2017;12:e0177762.
    Abstract    

    Abstract available

  157. JOO JH, Kim YS, Cho BC, Jeong CY, et al
    Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06).
    PLoS One. 2017;12:e0173476.
    Abstract    

    Abstract available

  158. ELMI AA, Bansal D, Acharya A, Skariah S, et al
    Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar.
    PLoS One. 2017;12:e0169197.
    Abstract    

    Abstract available

  159. MEISAL R, Rounge TB, Christiansen IK, Eieland AK, et al
    HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization.
    PLoS One. 2017;12:e0169074.
    Abstract    

    Abstract available

  160. BERNAUDO S, Khazai S, Honarparvar E, Kopteva A, et al
    Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.
    PLoS One. 2017;12:e0179906.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;